VSMS approval, page-6

Given that there’s no other adequate remote patient monitoring device for QT in hospitals, it wouldn’t be out of the question for the FDA to review and potentiall renew the approval after Covid19. That’s only speculation.
The way that Trump and the US are handling the Covid19 response will result in a lot of people being hospitalised, especially since they’ve started reopening the country again, until a vaccine is found and distributed which may be end of 2021.